Astone, Antonio
 Distribuzione geografica
Continente #
NA - Nord America 431
EU - Europa 425
AS - Asia 81
AF - Africa 6
SA - Sud America 2
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 947
Nazione #
US - Stati Uniti d'America 431
DE - Germania 155
SE - Svezia 102
CN - Cina 53
UA - Ucraina 39
IT - Italia 37
IE - Irlanda 27
GB - Regno Unito 18
FR - Francia 16
IN - India 13
FI - Finlandia 7
CI - Costa d'Avorio 6
IR - Iran 5
RS - Serbia 5
BE - Belgio 4
NL - Olanda 4
TR - Turchia 4
ES - Italia 3
CH - Svizzera 2
HK - Hong Kong 2
JP - Giappone 2
RU - Federazione Russa 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AT - Austria 1
AU - Australia 1
BG - Bulgaria 1
CL - Cile 1
CZ - Repubblica Ceca 1
ID - Indonesia 1
PE - Perù 1
PT - Portogallo 1
SA - Arabia Saudita 1
Totale 947
Città #
Chandler 108
Dublin 26
Ashburn 21
Jacksonville 18
San Mateo 18
Boston 13
Nanjing 13
New York 13
Ann Arbor 12
Princeton 11
Chicago 9
Dearborn 9
Wilmington 9
Hangzhou 8
Simi Valley 8
Houston 7
Milan 7
Abidjan 6
Falls Church 6
Los Angeles 6
Marseille 6
Woodbridge 6
Belgrade 5
Bologna 5
Nanchang 5
Nürnberg 5
Rome 5
Augusta 4
Fairfield 4
Fremont 4
Izmir 4
Leawood 4
Mountain View 4
Norwalk 4
Brussels 3
Cattolica 3
Changchun 3
Kunming 3
Redwood City 3
San Diego 3
Shenyang 3
Boardman 2
Bremen 2
Busto Arsizio 2
Hefei 2
Hong Kong 2
Hyderabad 2
Jiaxing 2
Jinan 2
Lawrence 2
Legnano 2
Madrid 2
Palermo 2
Stockholm 2
Tokyo 2
University Park 2
Zhengzhou 2
Zurich 2
Antwerp 1
Beijing 1
Cambridge 1
Charleston 1
Clearwater 1
Cormeilles-en-Parisis 1
Costa Mesa 1
Edinburgh 1
Fiesole 1
Fuzhou 1
Guangzhou 1
Haikou 1
Hebei 1
Hounslow 1
Kish 1
Lancaster 1
Lima 1
Lisbon 1
Miami 1
Monmouth Junction 1
Munich 1
Ningbo 1
Pantigliate 1
Paris 1
Phoenix 1
Pune 1
Redmond 1
Riyadh 1
San Francisco 1
Santiago 1
Seattle 1
Shaoxing 1
Sofia 1
Sydney 1
Tehran 1
Tettnang 1
Tianjin 1
Valencia 1
Zanjan 1
Totale 487
Nome #
Association of IL-8 and eNOS polymorphisms with clinical outcomes in bevacizumab-treated breast cancer patients: an exploratory analysis 139
Final analysis of colorectal cancer patients treated with irinotecan and 5-fluorouracil plus folinic acid neoadjuvant chemotherapy for unresectable liver metastases 120
AMAROS Study: Overall Survival in Breast Cancer Subtypes 102
Risk factors for intrahepatic recurrence of hepatocellular carcinoma in cirrhotic patients treated by percutaneous ethanol injection 94
The immune response to tumors as a tool toward immunotherapy 84
Advanced colon cancer: staging and prognosis by CEA test 77
Gas in portal circulation and pneumatosis cystoides intestinalis during chemotherapy for advanced rectal cancer 70
ERCC1 Induction after Oxaliplatin Exposure May Depend on KRAS Mutational Status in Colorectal Cancer Cell Line: In Vitro Veritas 62
Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting 48
Cdk4/6 inhibitor treatments in patients with hormone receptor positive, her2 negative advanced breast cancer: Potential molecular mechanisms, clinical implications and future perspectives 47
A Real-World Multicentre Retrospective Study of Paclitaxel-Bevacizumab and Maintenance Therapy as First-Line for HER2-Negative Metastatic Breast Cancer 44
Neoadjuvant chemotherapy in triple-negative breast cancer: A multicentric retrospective observational study in real-life setting 38
Body mass index in HER2-negative metastatic breast cancer treated with first-line paclitaxel and bevacizumab 30
Validation of the Meet-URO score in patients with metastatic renal cell carcinoma receiving first-line nivolumab and ipilimumab in the Italian Expanded Access Program 13
Totale 968
Categoria #
all - tutte 3.481
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.481


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201916 0 0 0 0 0 0 0 0 0 0 8 8
2019/2020109 17 9 2 7 5 8 17 4 7 8 17 8
2020/2021100 2 8 2 9 8 5 16 2 17 8 22 1
2021/2022134 8 6 1 16 9 6 4 19 5 8 21 31
2022/2023309 29 51 16 44 19 31 15 23 44 7 19 11
2023/202492 7 41 2 1 10 11 5 2 6 7 0 0
Totale 968